Kingsview Wealth Management LLC Increases Stock Holdings in Danaher Co. (NYSE:DHR)

Kingsview Wealth Management LLC lifted its stake in shares of Danaher Co. (NYSE:DHR) by 7.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 40,795 shares of the conglomerate’s stock after buying an additional 2,690 shares during the quarter. Kingsview Wealth Management LLC’s holdings in Danaher were worth $9,364,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. MWA Asset Management boosted its stake in Danaher by 13.7% in the fourth quarter. MWA Asset Management now owns 1,432 shares of the conglomerate’s stock valued at $329,000 after acquiring an additional 172 shares in the last quarter. Vest Financial LLC boosted its position in shares of Danaher by 12.2% in the 4th quarter. Vest Financial LLC now owns 3,088 shares of the conglomerate’s stock valued at $709,000 after purchasing an additional 336 shares during the period. Cidel Asset Management Inc. grew its stake in Danaher by 5.8% during the 4th quarter. Cidel Asset Management Inc. now owns 1,810 shares of the conglomerate’s stock worth $415,000 after buying an additional 100 shares during the last quarter. Conning Inc. increased its position in Danaher by 14.2% during the fourth quarter. Conning Inc. now owns 24,277 shares of the conglomerate’s stock worth $5,573,000 after buying an additional 3,018 shares during the period. Finally, Generate Investment Management Ltd purchased a new stake in Danaher in the fourth quarter valued at approximately $8,044,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Activity at Danaher

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders own 10.90% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Robert W. Baird cut their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Scotiabank initiated coverage on shares of Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 target price for the company. Guggenheim began coverage on Danaher in a report on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. UBS Group reduced their price objective on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 target price (down from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Seven equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average price target of $278.00.

Danaher Trading Down 1.5 %

Shares of DHR opened at $206.92 on Friday. Danaher Co. has a 1-year low of $205.79 and a 1-year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a 50 day simple moving average of $233.38 and a 200-day simple moving average of $252.10. The stock has a market cap of $149.45 billion, a price-to-earnings ratio of 39.19, a price-to-earnings-growth ratio of 2.80 and a beta of 0.83.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the business earned $2.09 earnings per share. Equities analysts forecast that Danaher Co. will post 7.77 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were issued a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.52%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.